A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Young Adult Survivors United
Eli Lilly and Company
Telix Pharmaceuticals (Innovations) Pty Limited
Eli Lilly and Company
Hutchmed
Elevation Oncology
IGM Biosciences, Inc.
Mayo Clinic
Shanghai PerHum Therapeutics Co., Ltd.
NantCell, Inc.
Washington University School of Medicine
Pfizer
pharmaand GmbH
Children's National Research Institute
Nektar Therapeutics
National Institutes of Health Clinical Center (CC)
MacroGenics
Seagen Inc.
Centre Leon Berard
National Institutes of Health Clinical Center (CC)
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
Yale University
CureOne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Western Regional Medical Center
MedInnovation GmbH
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of South Florida
Pfizer
National Cancer Institute (NCI)
Emory University